Rare Disease Treatment Market Report

China Rare Disease Treatment Industry Market Research Report 2023-2029

  • POSTDATE：Aug 27, 2023
  • PAGES：149
  • REPORT CODE：GMM1761045
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Rare Disease Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Alexion

    • AbbVie Inc

    • Novo Nordisk A/S

    • Pfizer Inc

    • Baxter

    • Amgen, Inc

    • F Hoffmann-La Roche Ltd

    • Teva Pharmaceutical Industries Ltd

    • Shire

    • Eisai Co Ltd

    • Allergan plc

    • Celgene Corporation

    • Sanofi

    • Merck & Co, Inc

    • BioMarin

    • Vertex Pharmaceuticals

    • Johnson & Johnson Services, Inc

    By Type:

    • Generic Drugs

    • Originator Drugs

    By Application:

    • Specialty Pharmacies

    • Retail Pharmacies

    • Hospital Pharmacies

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Rare Disease Treatment Market Overview 2018-2029

    • 1.1 China Rare Disease Treatment Industry Development Overview

    • 1.2 China Rare Disease Treatment Industry Development History

    • 1.3 China Rare Disease Treatment Industry Market Size (2018-2029)

    • 1.4 China Rare Disease Treatment Market Analysis by Type from Production Side

      • 1.4.1 China Rare Disease Treatment Production Volume, Production Value and Growth Rate of Generic Drugs (2018-2029)

      • 1.4.2 China Rare Disease Treatment Production Volume, Production Value and Growth Rate of Originator Drugs (2018-2029)

    • 1.5 China Rare Disease Treatment Market Analysis by Application from Consumption End

      • 1.5.1 China Rare Disease Treatment Sales Volume, Sales Value and Growth Rate of Specialty Pharmacies (2018-2029)

      • 1.5.2 China Rare Disease Treatment Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

      • 1.5.3 China Rare Disease Treatment Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

    • 1.6 China Rare Disease Treatment Market Analysis by Region

      • 1.6.1 North China Rare Disease Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Rare Disease Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Rare Disease Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Rare Disease Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Rare Disease Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Rare Disease Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Rare Disease Treatment Market Size and Growth Rate from 2018-2029

    Chapter 2 China Rare Disease Treatment Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Rare Disease Treatment Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Rare Disease Treatment Market Status and Competition Analysis in 2023

      • 2.2.3 China Rare Disease Treatment Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Rare Disease Treatment Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Rare Disease Treatment Industry Development

    Chapter 3 Rare Disease TreatmentIndustry Chain Analysis

    • 3.1 Rare Disease Treatment Industry Chain

    • 3.2 Rare Disease Treatment Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Rare Disease Treatment Market

    • 3.3 Rare Disease Treatment Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Rare Disease Treatment Market

    Chapter 4 China Rare Disease Treatment Market, by Type

    • 4.1 China Rare Disease Treatment Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Rare Disease Treatment Total Production Volume and Growth Rate from Production Side

    • 4.5 China Rare Disease Treatment Production Volume and Growth Rate, by Type

      • 4.5.1 China Rare Disease Treatment Production Volume and Growth Rate of Generic Drugs

      • 4.5.2 China Rare Disease Treatment Production Volume and Growth Rate of Originator Drugs

    Chapter 5 China Rare Disease Treatment Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Rare Disease Treatment Total Market Size and Growth Rate from Consumption End

    • 5.5 China Rare Disease Treatment Market Size and Growth Rate, by Application

      • 5.5.1 China Rare Disease Treatment Market Size and Growth Rate of Specialty Pharmacies

      • 5.5.2 China Rare Disease Treatment Market Size and Growth Rate of Retail Pharmacies

      • 5.5.3 China Rare Disease Treatment Market Size and Growth Rate of Hospital Pharmacies

    Chapter 6 China Rare Disease Treatment Market, by Region

    • 6.1 China Rare Disease Treatment Production Volume and Production Value, by Region

    • 6.2 China Rare Disease Treatment Sales Volume and Sales Value, by Region

    Chapter 7 North China Rare Disease Treatment Market Analysis

    • 7.1 North China Rare Disease Treatment Market, by Type

    • 7.2 North China Rare Disease Treatment Market, by Application

    Chapter 8 Central China Rare Disease Treatment Market Analysis

    • 8.1 Central China Rare Disease Treatment Market, by Type

    • 8.2 Central China Rare Disease Treatment Market, by Application

    Chapter 9 South China Rare Disease Treatment Market Analysis

    • 9.1 South China Rare Disease Treatment Market, by Type

    • 9.2 South China Rare Disease Treatment Market, by Application

    Chapter 10 East China Rare Disease Treatment Market Analysis

    • 10.1 East China Rare Disease Treatment Market, by Type

    • 10.2 East China Rare Disease Treatment Market, by Application

    Chapter 11 Northeast China Rare Disease Treatment Market Analysis

    • 11.1 Northeast China Rare Disease Treatment Market, by Type

    • 11.2 Northeast China Rare Disease Treatment Market, by Application

    Chapter 12 Southwest China Rare Disease Treatment Market Analysis

    • 12.1 Southwest China Rare Disease Treatment Market, by Type

    • 12.2 Southwest China Rare Disease Treatment Market, by Application

    Chapter 13 Northwest China Rare Disease Treatment Market Analysis

    • 13.1 Northwest China Rare Disease Treatment Market, by Type

    • 13.2 Northwest China Rare Disease Treatment Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Alexion

        • 14.1.1 Alexion Company Profile

        • 14.1.2 Alexion Rare Disease Treatment Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 AbbVie Inc

        • 14.2.1 AbbVie Inc Company Profile

        • 14.2.2 AbbVie Inc Rare Disease Treatment Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Novo Nordisk A/S

        • 14.3.1 Novo Nordisk A/S Company Profile

        • 14.3.2 Novo Nordisk A/S Rare Disease Treatment Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Pfizer Inc

        • 14.4.1 Pfizer Inc Company Profile

        • 14.4.2 Pfizer Inc Rare Disease Treatment Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Baxter

        • 14.5.1 Baxter Company Profile

        • 14.5.2 Baxter Rare Disease Treatment Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Amgen, Inc

        • 14.6.1 Amgen, Inc Company Profile

        • 14.6.2 Amgen, Inc Rare Disease Treatment Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 F Hoffmann-La Roche Ltd

        • 14.7.1 F Hoffmann-La Roche Ltd Company Profile

        • 14.7.2 F Hoffmann-La Roche Ltd Rare Disease Treatment Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Teva Pharmaceutical Industries Ltd

        • 14.8.1 Teva Pharmaceutical Industries Ltd Company Profile

        • 14.8.2 Teva Pharmaceutical Industries Ltd Rare Disease Treatment Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Shire

        • 14.9.1 Shire Company Profile

        • 14.9.2 Shire Rare Disease Treatment Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Eisai Co Ltd

        • 14.10.1 Eisai Co Ltd Company Profile

        • 14.10.2 Eisai Co Ltd Rare Disease Treatment Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Allergan plc

        • 14.11.1 Allergan plc Company Profile

        • 14.11.2 Allergan plc Rare Disease Treatment Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Celgene Corporation

        • 14.12.1 Celgene Corporation Company Profile

        • 14.12.2 Celgene Corporation Rare Disease Treatment Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Sanofi

        • 14.13.1 Sanofi Company Profile

        • 14.13.2 Sanofi Rare Disease Treatment Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Merck & Co, Inc

        • 14.14.1 Merck & Co, Inc Company Profile

        • 14.14.2 Merck & Co, Inc Rare Disease Treatment Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 BioMarin

        • 14.15.1 BioMarin Company Profile

        • 14.15.2 BioMarin Rare Disease Treatment Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Vertex Pharmaceuticals

        • 14.16.1 Vertex Pharmaceuticals Company Profile

        • 14.16.2 Vertex Pharmaceuticals Rare Disease Treatment Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Johnson & Johnson Services, Inc

        • 14.17.1 Johnson & Johnson Services, Inc Company Profile

        • 14.17.2 Johnson & Johnson Services, Inc Rare Disease Treatment Market Performance

        • 14.17.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Rare Disease Treatment Industry Research Conclusions

    • 15.2 Rare Disease Treatment Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Rare Disease Treatment Industry Market Size (2018-2029)

    • Figure China Rare Disease Treatment Production Volume, Production Value and Growth Rate of Generic Drugs (2018-2029)

    • Figure China Rare Disease Treatment Production Volume, Production Value and Growth Rate of Originator Drugs (2018-2029)

    • Figure China Rare Disease Treatment Sales Volume, Sales Value and Growth Rate of Specialty Pharmacies (2018-2029)

    • Figure China Rare Disease Treatment Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

    • Figure China Rare Disease Treatment Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

    • Figure North China Rare Disease Treatment Market Size and Growth Rate from 2018-2029

    • Figure Central China Rare Disease Treatment Market Size and Growth Rate from 2018-2029

    • Figure South China Rare Disease Treatment Market Size and Growth Rate from 2018-2029

    • Figure East China Rare Disease Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Rare Disease Treatment Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Rare Disease Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Rare Disease Treatment Market Size and Growth Rate from 2018-2029

    • Figure Rare Disease Treatment Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Rare Disease Treatment Market Share by Type in 2018

    • Figure China Rare Disease Treatment Market Share by Type in 2023

    • Figure China Rare Disease Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Rare Disease Treatment Production Volume and Growth Rate of Generic Drugs (2018-2023)

    • Figure China Rare Disease Treatment Production Volume and Growth Rate of Originator Drugs (2018-2023)

    • Figure China Rare Disease Treatment Market Share by Application in 2018

    • Figure China Rare Disease Treatment Market Share by Application in 2023

    • Figure China Rare Disease Treatment Total Market Size and Growth Rate from Consumption End

    • Figure China Rare Disease Treatment Market Size and Growth Rate of Specialty Pharmacies (2018-2023)

    • Figure China Rare Disease Treatment Market Size and Growth Rate of Retail Pharmacies (2018-2023)

    • Figure China Rare Disease Treatment Market Size and Growth Rate of Hospital Pharmacies (2018-2023)

    • Table China Rare Disease Treatment Production Volume by Region (2018-2023)

    • Table China Rare Disease Treatment Production Volume Share by Region (2018-2023)

    • Figure China Rare Disease Treatment Production Volume Share by Region (2018-2023)

    • Table China Rare Disease Treatment Production Value by Region (2018-2023)

    • Table China Rare Disease Treatment Production Value Share by Region (2018-2023)

    • Figure China Rare Disease Treatment Production Value Share by Region (2018-2023)

    • Table China Rare Disease Treatment Sales Volume by Region (2018-2023)

    • Table China Rare Disease Treatment Sales Volume Share by Region (2018-2023)

    • Figure China Rare Disease Treatment Sales Volume Share by Region (2018-2023)

    • Table China Rare Disease Treatment Sales Value by Region (2018-2023)

    • Table China Rare Disease Treatment Sales Value Share by Region (2018-2023)

    • Figure China Rare Disease Treatment Sales Value Share by Region (2018-2023)

    • Table North China Rare Disease Treatment Production Volume by Type (2018-2023)

    • Table North China Rare Disease Treatment Production Volume Share by Type (2018-2023)

    • Figure North China Rare Disease Treatment Production Volume Share by Type (2018-2023)

    • Table North China Rare Disease Treatment Sales Volume by Application (2018-2023)

    • Table North China Rare Disease Treatment Sales Volume Share by Application (2018-2023)

    • Figure North China Rare Disease Treatment Sales Volume Share by Application (2018-2023)

    • Table Central China Rare Disease Treatment Production Volume by Type (2018-2023)

    • Table Central China Rare Disease Treatment Production Volume Share by Type (2018-2023)

    • Figure Central China Rare Disease Treatment Production Volume Share by Type (2018-2023)

    • Table Central China Rare Disease Treatment Sales Volume by Application (2018-2023)

    • Table Central China Rare Disease Treatment Sales Volume Share by Application (2018-2023)

    • Figure Central China Rare Disease Treatment Sales Volume Share by Application (2018-2023)

    • Table South China Rare Disease Treatment Production Volume by Type (2018-2023)

    • Table South China Rare Disease Treatment Production Volume Share by Type (2018-2023)

    • Figure South China Rare Disease Treatment Production Volume Share by Type (2018-2023)

    • Table South China Rare Disease Treatment Sales Volume by Application (2018-2023)

    • Table South China Rare Disease Treatment Sales Volume Share by Application (2018-2023)

    • Figure South China Rare Disease Treatment Sales Volume Share by Application (2018-2023)

    • Table East China Rare Disease Treatment Production Volume by Type (2018-2023)

    • Table East China Rare Disease Treatment Production Volume Share by Type (2018-2023)

    • Figure East China Rare Disease Treatment Production Volume Share by Type (2018-2023)

    • Table East China Rare Disease Treatment Sales Volume by Application (2018-2023)

    • Table East China Rare Disease Treatment Sales Volume Share by Application (2018-2023)

    • Figure East China Rare Disease Treatment Sales Volume Share by Application (2018-2023)

    • Table Northeast China Rare Disease Treatment Production Volume by Type (2018-2023)

    • Table Northeast China Rare Disease Treatment Production Volume Share by Type (2018-2023)

    • Figure Northeast China Rare Disease Treatment Production Volume Share by Type (2018-2023)

    • Table Northeast China Rare Disease Treatment Sales Volume by Application (2018-2023)

    • Table Northeast China Rare Disease Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Rare Disease Treatment Sales Volume Share by Application (2018-2023)

    • Table Southwest China Rare Disease Treatment Production Volume by Type (2018-2023)

    • Table Southwest China Rare Disease Treatment Production Volume Share by Type (2018-2023)

    • Figure Southwest China Rare Disease Treatment Production Volume Share by Type (2018-2023)

    • Table Southwest China Rare Disease Treatment Sales Volume by Application (2018-2023)

    • Table Southwest China Rare Disease Treatment Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Rare Disease Treatment Sales Volume Share by Application (2018-2023)

    • Table Northwest China Rare Disease Treatment Production Volume by Type (2018-2023)

    • Table Northwest China Rare Disease Treatment Production Volume Share by Type (2018-2023)

    • Figure Northwest China Rare Disease Treatment Production Volume Share by Type (2018-2023)

    • Table Northwest China Rare Disease Treatment Sales Volume by Application (2018-2023)

    • Table Northwest China Rare Disease Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Rare Disease Treatment Sales Volume Share by Application (2018-2023)

    • Table Alexion Company Profile

    • Table Alexion Rare Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table AbbVie Inc Company Profile

    • Table AbbVie Inc Rare Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table Novo Nordisk A/S Company Profile

    • Table Novo Nordisk A/S Rare Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table Pfizer Inc Company Profile

    • Table Pfizer Inc Rare Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table Baxter Company Profile

    • Table Baxter Rare Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table Amgen, Inc Company Profile

    • Table Amgen, Inc Rare Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche Ltd Company Profile

    • Table F Hoffmann-La Roche Ltd Rare Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Industries Ltd Company Profile

    • Table Teva Pharmaceutical Industries Ltd Rare Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table Shire Company Profile

    • Table Shire Rare Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table Eisai Co Ltd Company Profile

    • Table Eisai Co Ltd Rare Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table Allergan plc Company Profile

    • Table Allergan plc Rare Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table Celgene Corporation Company Profile

    • Table Celgene Corporation Rare Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Rare Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table Merck & Co, Inc Company Profile

    • Table Merck & Co, Inc Rare Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table BioMarin Company Profile

    • Table BioMarin Rare Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table Vertex Pharmaceuticals Company Profile

    • Table Vertex Pharmaceuticals Rare Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Services, Inc Company Profile

    • Table Johnson & Johnson Services, Inc Rare Disease Treatment Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US